What this site is

An access-restricted watchlist and newsroom. The lists cover a bionics & neurotech theme, humanoid & general robotics, the large US technology and blue-chip companies, the DAX, large European companies, China & Hong Kong and Asia-Pacific — plus the main indices, currencies, commodities and rates for context. Listed securities show delayed quotes so you can see movement at a glance; private companies are tracked for news only; optional alerts tell you when something happens. Accounts are created by an administrator or with an invite code — this is not a public product.

This site does not create its own index and does not claim to be one.

• Not a licensed or official index — and not a benchmark used to price a financial product.
• Not a fund, ETF, or anything you can buy.
• Not a broker. You cannot place an order, hold a portfolio, or execute a trade here.
• Not investment advice and not a recommendation to buy or sell anything.

A published index — S&P, MSCI, MVIS, DAX — has a licensed methodology, a calculation agent, a rebalancing calendar, and is often the basis for investable products. We do not do that, and we do not claim to.

The bionics list carries one editorial figure: the median daily percent move of the listed pure-play companies we follow. It is a same-day reading of names on our list. It has no base value, no back-calculated history, and nothing you can invest in. Every other list simply shows how many names rose or fell and the mean move.

If you want a published thematic benchmark, the closest one we show for context is VanEck’s Medical Robotics & Bionic Engineering ETF (CIB0), which tracks the MVIS Global Bionic Healthcare index. That is their product, not ours. The real indices on the Today page — DAX, Euro Stoxx 50, S&P 500, Nasdaq, Hang Seng, Nikkei — are quoted as published by their providers.

Counted today across 36 listed pure-plays. The rules are editorial, written down here so nobody has to guess.

• Only listed companies marked as a pure play — bionics is the core business, not a side division.
• Only the six bionics sectors: prosthetics, exoskeletons, neurotech, senses, organs, surgical and rehab robotics.
• Humanoid and general robotics is a list of its own, not part of the figure — a Tesla or Fanuc headline must not swing the median.
• Equal-weighted median of today’s percent change. A cap-weighted figure sits next to it for context.
• No base value, no rebalancing schedule, no “index level” that compounds over time.
• Not investable. It is a reading of the names we already follow, not a product.

The lists hold 236 listed securities and 50 private companies. Inclusion is editorial, not a mechanical index universe.

• Themed lists (bionics, robotics): the company’s core business is in the theme, or it has a material division that is. Pure-plays and diversified groups are labelled so a $190 B device company is never mistaken for a $20 M implant name.
• Regional lists (US, DAX, Europe, China, Asia-Pacific): the largest and most-followed companies of each market — the DAX list is the current 40 constituents.
• Private companies appear for news only — no quote, no weight anywhere.
• Names are added or removed when listings, acquisitions or strategy changes take them in or out. The lists are reviewed; they are not rebalanced on a calendar.

Quotes come from Yahoo Finance and are delayed by exchange. News is pulled from filings, wires, central banks, business and trade press and aggregators. The server fetches all of it — your browser never talks to those sources. Figures are without warranty. Alerts only notify; they never place an order.